To determine the percentage of family medicine residency programs that have pharmacists directly involved in teaching residents, the types and extent of teaching provided by pharmacists in family medicine residency programs, and the primary source of funding for the pharmacists.
One hundred fifty-eight resident training sites within the 17 family medicine residency programs in Canada.
One hundred residency program directors who were responsible for overseeing the training sites within the residency programs were contacted to determine the percentage of training sites in which pharmacists were directly involved in teaching. Pharmacists who were identified by the residency directors were invited to participate in the Web-based survey.
The percentage of training sites for family medicine residency that have pharmacists directly involved in teaching residents. The types and the extent of teaching performed by the pharmacists who teach in the residency programs. The primary source of funding that supports the pharmacists' salaries.
More than a quarter (25.3%) of family medicine residency training sites include direct involvement of pharmacist teachers. Pharmacist teachers reported that they spend a substantial amount of their time teaching residents using a range of teaching modalities and topics, but have no formal pharmacotherapy curriculums. Nearly a quarter (22.6%) of the pharmacists reported that their salaries were primarily funded by the residency programs.
Pharmacists have a role in training family medicine residents. This is a good opportunity for family medicine residents to learn about issues related to pharmacotherapy; however, the role of pharmacists as educators might be optimized if standardized teaching methods, curriculums, and evaluation plans were in place.
Cites: Fam Med. 2002 Oct;34(9):653-712455248
Cites: Fam Med. 2002 Oct;34(9):692-312455255
Cites: J Fam Pract. 1981 Jul;13(1):91-47252442
Cites: Can Fam Physician. 2008 Dec;54(12):1714-1717.e519074716
Cites: Can Fam Physician. 1994 Mar;40:468-718199502
Cites: J Am Pharm Assoc (2003). 2008 Mar-Apr;48(2):203-11; 3 p following 21118359733